The 11th Annual BIO CEO & Investor Conference
February 9-10, 2009
Waldorf-Astoria
New York City

Thank you for making the 11th Annual BIO CEO & Investor Conference a great success!

BIO CEO & Investor Conference remains to be the largest investor conference focused on publicly traded biotech companies. Because BIO’s mission is to support industry-wide success, we present a broad and unbiased view of investment opportunities.

BIO’s therapeutic workshops feature the latest information on pipeline innovation, and no other investor conference offers as many sessions involving MDs, CSOs, and industry analysts.

BIO’s One-on-One Partnering also provides an opportunity to arrange meetings between investors; companies; and industry BD, licensing and therapeutic franchise heads.

Don't Miss These Top-level Speakers!

Don't Miss These Presenting Companies!

Click here for a PDF of the Presenting Schedule

View the Interactive Presenting Company Index

Advisory Committee

Ben Perkins	Wedbush Pacific Growth Life Sciences
Kelly Lisbakken	Wedbush Pacific Growth Life Sciences
Mike King	Rodman & Renshaw
David Kroin	Great Point Partners, LLC
David Nikodem	BNP Paribas
Ryan Ogg	Visium Asset Management, LLC
Eric Schmidt	Cowen & Company, LLC
Mark Schoenbaum	Deutsche Bank Securities, Inc

For more information, please contact BIO CEO customer service:
Email: biopartnering@bio.org,
Phone: 866.356.5155, +1.202.962.6666

Participating Investors

203 Investment Partners LLP
1798 Global Partners
A.M. Pappas & Associates, LLC
Aberdeen Asset Management
Aceras BioMedical, LLC
Accipiter Capital Management
Actin Biomed
Aduro Capital LLC
Advent Capital Management
AgeChem Financial
AIG Global Investment Group
Aisling Capital
AllianceBernstein
AM Investment Partners
Amphion Innovations
Arcoda Capital
Arcus Ventures
Ardana Capital Management
Ares Life Sciences
Arnhold and S Bleichroeder Advisers
Array Capital Management, LLC
Ascent Biomedical Holdings (ABH)
Atypical BioCapital Management LLC
Axiom Venture Partners
Bailard, Inc.
Baker Brothers Investments
BAM Capital
Banc of America Securities/Merrill Lynch
Barclays Capital
BBL Biomedical
BDR Research Group
BioHermes
BioRevolution Capital, LLC
Biotechnology Value Fund
Black Diamond Advisers
BladeRock Capital
Bloom Burton & Co.
Blumberg Capital Management
BMO Capital Markets
BMS Strategic Venture
Boenning & Scattergood
Brean Murray
Brencourt Advisors
Bridger Capital
Broadfin Capital
BSI Healthcapital SA
BWS Financial
Caledonian Private Equity
Camber Capital Management
Canaccord Adams
Cantor Fitzgerald
Capital Midwest Fund
Capstone Investments
Care Capital LLC
Carlyle Blue Wave
Casdin Advisors LLC
Catapult Capital
Cato BioVentures
Caxton Advantage Venture Partners
CCI Healthcare Partners
Celtic Therapeutics LP
Charlestown Capital Advisors, LLC
Chilton Investment Company
CHL Medical Partners
Citi
CLC
Collins Stewart
Columbia Management Advisors
Cowen & Company, LLC
Cowen Healthcare Royalty Partners
CR Intrinsic
Cummings Bay Capital
Dabar Investment Associates
DD Venture Fund
Deerfield Management
Delaware Investments
Delwar Capital
Diker Management
DRI Capital
DSM Capital
Eagle Asset Management
East Hill Management Company
Easton Capital
EGB Ventures
EGS Healthcare Capital Partners
Emerald Asset Management Inc.
Emergent Medical Partners
Eminent Venture Capital Corporation
EuclidSR Partners, LP
Fidelity - Pyramis Global Advisors
Fidelity Investments
First Island Capital, Inc
FMB Research
FMG
Forest Investment Management
ForeThought
Fortis Investments
Fortress Investment Group
Fountain Healthcare Partners
Fred Alger
Fremont Ventures
Furgueson Capital Management
Fusion Capital Partners
The Galleon Group
Garrison, Bradford & Associates
Gemsco Capital
General American Investors, Inc.
Geneva Investment Management
George Weiss Associates
GGS Capital
GMA Capital LLC
Goldman, Sachs & Co
Great Point Partners
Griffin Securities, Inc.
Hambrecht & Quist Capital
Hapoalim Securities USA
Harbor Watch Capital Management
Harvest Management
HCI Advisors
HealthCare 250 LP
Healthcare Value Capital
Healthcor Management, LP
Helix Management
H.I.G. Ventures
Highside Capital Management
Hill & Associates
HK & Associates
Horizon Technology Ventures
Icahn Capital LP
Investor Growth Capital
The Invus Group
Issaquena Trust
J&J Development Corporation
J Goldman & Co
JAFCO Life Science Investment
Jefferies and Co
Jina Ventures
JMP Securities
JP Morgan
JPG Healthcare LLC
Johnston Associates Inc.
JW Asset Management
Katz Associates
KBL Healthcare Ventures
Kingdon Capital Management
Kingsbridge Capital
Kleiner Perkins Caufield & Byers
KMD Ventures
Knoll Capital Management, LP
Knott Partners, LP
L Capital Partners
Ladenburg Thalmann & Co
Lazard Asset Management
Lazard Capital Markets
Ledgemont Capital
Leerink Swan, LLC
Legg Mason
Life Science Partners
LifeScience EquityPartners, LLC
Liss Investments
Little Gem Life Sciences
Loeb Partners
Logical Ventures
Longitude Capital
Lord Abbett & Co.
Lux Research Inc.
Mackay Shields
Maple Leaf Partners
Maven Biocapital LLC
Maxim Group
Mayfair Capital Partners, Inc
Mazama Capital Management
MC Life Science Ventures (Mitsubishi)
MD Becker Parners LLC
MDB Capital Group LLC
MedImmune Ventures
MediValu
Mentor Capital Partners Ltd
Merriman Curhan Ford
Miller Tabak
Monness Crespi Hardt
Montaur Capital
Morgan Stanley
MP Asset Managers
MP Healthcare Venture
MPM Capital
Mymensingh Partners
Nano-Cap New Millenium Growth Fund LP
Natixis Bleichroeder, Inc.
NDI Capital Inc.
Needham & Co
NeoMed Management
NeuroVentures Capital
New Enterprise Associates
New Leaf Venture Partners
Nextech Manager LLC
NextStep Capital
NGN Capital LLC
NJTC Venture Fund
Nobel Financial
Nordic Biotech Fund
Northgate Partners
Novartis Option Fund
Novo A/S
Number One Corporation
Nutmeg Securities Ltd
Olayan Group
Omega Funds
Omni Capital Corporation
OneLife Advisors SA
OppenheimerFund
Opus Point Healthcare Partners
Oracle Investment Management
OrbiMed Advisors
OrbiMed Advisors India Private Limited
OSS Capital
Outer Islands Capital
Pacific Rim Ventures
Paisley and Habermas, Inc.
Paperboy Ventures LLC
Pappas Ventures
Passport Capital
Paul Capital Healthcare
Paulson Capital
Paw Partners
Perceptive Advisors
Perseus, LLC
Pharma Capital Partners
Pioneer Investments
Piper Jaffray
POSCO BioVentures
PricewaterhouseCoopers
Princeton Capital Management Inc.
Principled Capital Management
QuestRion
QVT Financial LP
Radius Ventures
Ram Partners, LP
RBC Capital Markets
Red Abbey Venture Partners
Redmile Group
ReqMed Company, Ltd
Revach Fund LP
The RH Barsom Company Inc.
Ridgeback Capital Management
Ridgemark Capital
Roche
Rodman & Renshaw
Royal Investments LLC
Royalty Pharma
RRC
SCM
S Squared Technology Corp.
SAC Capital Advisors
Sagamore Capital
Samtheo Biopharma LLC
Scimitar Equity, LLC
SCO Capital Partners
Sectoral Asset Management
Sems Capital LLC
Sherbrook Capital Management, LLC
Sichel Medical Ventures
Sio Capital Management
Sit Investment Associates
Skyline Ventures
Special Situation Funds
Spencer Trask
Spiro Capital Management, Inc.
SPRI Clinical Trials
SR One
Standard Life Investments
Stanford Group Company
Sterling Atlantic LLC
Strauss Asset Management
Stuyvesant Capital Partners
Suffolk Capital Management
Sumitomo Corporation of America
Summer Street Research Partners
Sunrise Equity Partners
Susquehanna
SV Life Sciences
Symbios Partners LLC
Symmetry Capital
Symphony Capital LLC
T.Rowe Price
Tanaka Capital Management
Tang Capital Management, LLC
The Channel Group, LLC
ThinkEquity
Thomas, McNerney & Partners
Thomas Weisel Partners
Thomson Reuters
Tianjin International Biopharmaceutical Fund
Titan Capital Management
Tocqueville Asset Management
Tokum Capital Management
Triple Peak Capital
Turner Investment Partners
TVM Capital
Two River Group Holdings, LLC
UBS Global Asset Management
Vanadium Capital Management
Venrock
Ventures West Capital
Vision Capital Advisors
Visium Asset Management
Wachovia Capital Markets, LLC
Wafra Investment Advisory Group
WBB Securities, LLC
Wedbush Pacific Growth Life Sciences
Weisbrod Family
Weiss Multi-Strategy Advisors
Westfield Capital Management Co.
Westport Capital Markets, LLC
Wexford Capital LLC
William Harris Investors, Inc
Winslow Management Company
Wolf Capital Management
World Technology Ventures, LLC
Yasuda Enterprise Development America Inc
Yorkville Advisors
Young Capital Partners
Xmark Opportunity Partners